JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suter, Peter. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suter, Peter. M.
Anesth Analg 2000;90:1236-1237
© 2000 International Anesthesia Research Society


CASE REPORTS

Intensive Care Medicine 2000: First Signs of Maturity?

Peter. M. Suter, MD

Surgical Intensive care, University Hospital, Geneva, Switzerland

Address correspondence and reprint requests to Peter M. Suter, MD, Surgical Intensive Care, University Hospital, CH-1211, Genève, Switzerland.


    Introduction
 Top
 Introduction
 References
 
After 40 years of a stormy development, the field of intensive care medicine had gained a firm place in the present hospital structure, but there is still room for significant improvements.

What are the major advances in this field during the last 10 years? There are certainly too many to be mentioned here, so I feel obliged to make an arbitrary selection, retaining educational and organizational achievements, ventilation-induced lung injury, and new therapies for sepsis and septic shock.

By whom should the critically ill be treated today? The 1990s have clearly confirmed the survival advantage provided for the patient by a professional approach in intensive care medicine. As in the majority of the other medical specialities, full time intensive care unit physicians with the appropriate, officially recognized training and board certification, seem not only to treat patients more efficiently, reducing mortality, but are also more cost efficient than other professionals (1,2). In addition, the resulting team approach and responsibility improve organization and management significantly.

In the presence of so much strong evidence for this professional scheme, it is surprising that, in many European countries, such official training and certification guidelines still do not exist, and that full time intensivists are often not available. Less surprisingly, research and scientific publications continue to be of lower quality in countries in which a speciality formation/training and separate board for intensive care medicine are not recognized.

Certainly, there has been a renewed interest in respiratory mechanics and "adapted" modes of mechanical ventilation during the last few years based on convincing animal data. The first clinical studies suggest evidence for the clinical reality of ventilator-induced lung injury, and, more importantly, its potential influence on outcome (1a,37).

These data have already profoundly changed the management of respiratory failure and mechanical ventilation during the last decade. Outcome studies suggest that mortality in one of the severest forms of acute respiratory failure, i.e., acute respiratory distress syndrome, has markedly declined since the 1980s, possibly as the consequence of lung protective strategies of ventilation and an improvement in general intensive care (8). These results are an occasion for some optimism in the field.

The last decade has not provided much reason for optimism, however, for the therapy of sepsis and septic shock. Despite important advances in our understanding of the mechanisms leading to the clinical picture and the often dismal outcome in this disease, the identification of important mediators and neutralizing proteins, all specific therapeutic interventions have failed so far to improve prognosis, even though many new therapies have been tested in appropriate randomized, double-blinded trials, including early corticosteroids and other antiinflammatory drugs, mediator neutralizing drugs, such as antitumor necrosis factor antibodies, antiinterleukins, and augmentation of systemic oxygen transport (913).

Thus, although many important advances have been made in the field of intensive care medicine during the last decade of the 20th century, there remain vast areas in which understanding and management must be improved; these include acute central nervous system diseases, cost-effectiveness analysis, and ethical questions overall related to end-of-life issues (14,15). These and other domains remain to be addressed, not only by the specialists in intensive care medicine, but also by large interdisciplinary discussion groups, including citizens and patient associations.


    Footnotes
 
PMS is the Section Editor for Critical Care and Trauma.


    References
 Top
 Introduction
 References
 

  1. Reynolds HN, Haupt MT, Thill-Baharozian MC, Carlson RW. Impact of critical care physician staffing on patients with septic shock in a university hospital medical intensive care unit. JAMA 1988;260:3446–50.[Abstract]
  2. Brown JJ, Sullivan G. Effect of ICU mortality of a full-time critical care specialist. Chest 1989;96:127–9.[Abstract/Free Full Text]
  3. Amato MBP, Barbas CSV, Medeiros DM, et al. Effect of protective-ventilation strategy on mortality in the acute respiratory distress syndrome, ARDS, ventilatory modes. N Engl J Med 1998;338:347–54.[Abstract/Free Full Text]
  4. National Institutes of Health. ARDS Network. Available at http://hedwig.mgh.harvard.edu/ardsnet/justvent911/.html. Accessed February 7, 2000.
  5. Dreyfuss D, Saumon G. Role of tidal volume, FRC, and end-inspiratory volume in the development of pulmonary edema following mechanical ventilation. Dis 1993;148:1194–203.
  6. Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999;282:54–61.[Abstract/Free Full Text]
  7. Slutsky AS, Tremblay LN. Multiple system organ failure: is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998;157:1721–5.[Free Full Text]
  8. Tremblay L, Valenza F, Ribeiro SP, et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung mode. J Clin Invest 1997;99:1–9.[ISI][Medline]
  9. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983–1993. JAMA 1995;273:306–9.[Abstract]
  10. Vincent JL. Search for effective immunomodulating strategies against sepsis. Lancet 1998;351:922–3.[ISI][Medline]
  11. Abraham E, Glauser MP, Butler TH, et al. P 55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock: a randomized controlled multicenter trial. JAMA 1997;277:1531–8.[Abstract]
  12. Angus DC, Birmingham MC, Balk RA, et al. E5 murine monoclonal antiendotoxin antibody in Gram-negative sepsis: a randomized controlled trial. JAMA 2000;283:1723–30.[Abstract/Free Full Text]
  13. Hayes MA, Timmins AC, Yau EH, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994:330:1717–23.
  14. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. Med 1995;333:1025–32.[Abstract/Free Full Text]
  15. Truog RD, Burns JP, Mitchell CH, et al. Pharmacologic paralysis and withdrawl of mechanical ventilation at the end of life. Engl J Med 2000;342:508–11.[Free Full Text]
  16. Pellegrino ED. Decisions to withdraw life-sustaining treatment: a moral algorithm. JAMA 2000;283:1065–7.[Free Full Text]
Accepted for publication February 25, 2000.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suter, Peter. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suter, Peter. M.


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press